1-5 of 5
Konstantin Byrgazov, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Anti-Myeloma Drug Melflufen Inhibits RANKL-Stimulated Osteoclastogenesis By Suppressing Proliferation of CD14+ Precursor Cells

Konstantin Byrgazov, PhD, Annica Rasmusson, Claes Andersson, Malin Berglund, Lena Lenhammar, Håkan Melhus, Joachim Gullbo, Ana Slipicevic, Fredrik Lehmann, Rolf Larsson, Thomas Lind, Mårten Fryknäs
Journal: Blood
Blood (2020) 136 (Supplement 1): 23.
https://doi.org/10.1182/blood-2020-136749
Published: 2020
Journal Articles

Effect of ABCB1 Multidrug Resistance Protein on Efficacy of Anti-Myeloma Drugs in Carfilzomib-Resistant Myeloma Model

Konstantin Byrgazov, PhD, Marianne Kraus, Andrej Besse, Ana Slipicevic, Fredrik Lehmann, Christoph Driessen, MD, Lenka Besse
Journal: Blood
Blood (2020) 136 (Supplement 1): 36–37.
https://doi.org/10.1182/blood-2020-136725
Published: 2020
Journal Articles

Combined Targeting of STAT3 and STAT5: A Novel Approach to Overcome Drug Resistance in Ph + Cml

Karoline V Gleixner, MD, Mathias A Schneeweiss, MD, Harald Herrmann, MD, Katharina Blatt, MSc, PhD, Daniela Berger, Gregor Eisenwort, MD PhD, Georg Greiner, MD, Konstantin Byrgazov, PhD, Gregor Hoermann, Marina Konopleva, MD PhD, Islam Waliul, Patrick T Gunning, PhD, Hiroshi Maeda, PhD, Richard Moriggl, PhD, Michael W. Deininger, MD PhD, Thomas Lion, PhD, Michael Andreeff, MD PhD, Peter Valent, MD
Journal: Blood
Blood (2016) 128 (22): 4241.
https://doi.org/10.1182/blood.V128.22.4241.4241
Published: 2016
Journal Articles

Hydroxyurea Induces Growth Inhibition in BCR-ABL1 T315I+ Clones and Synergizes with Ponatinib in Killing TKI-Resistant CML Cells

Mathias A Schneeweiss, MD, Konstantin Byrgazov, PhD, Chantal B Lucini, PhD, Susanne Herndlhofer, Wolfgang R. Sperr, MD, Thomas Lion, PhD, Gregor Hoermann, Michael W. Deininger, MD PhD, Peter Valent, MD, Karoline V Gleixner, MD
Journal: Blood
Blood (2016) 128 (22): 5425.
https://doi.org/10.1182/blood.V128.22.5425.5425
Published: 2016
Journal Articles

A Novel Fusion Gene NDEL1-Pdgfrb in a Patient with JMML with a New Variant of TKI-Resistant Mutation in the Kinase Domain of PDGFRβ

Konstantin Byrgazov, PhD, Renate Kastner, PhD, Michael Dworzak, MD, Gregor Hoermann, MD PhD, Oskar A. Haas, MD, Raphael Ulreich, MD, Christian E. Urban, MD, Oliver D. Hantschel, PhD, Peter Valent, MD, Thomas Lion, MD PhD
Journal: Blood
Blood (2014) 124 (21): 613.
https://doi.org/10.1182/blood.V124.21.613.613
Published: 2014